Global Nifedipine Injection 麻豆原创 Research Report 2025

Publication ID:

PB502253191

Publication Date:

February 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Nifedipine Injection was valued at US$ 85.8 million in the year 2024 and is projected to reach a revised size of US$ 104 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Nifedipine Injection is a calcium channel blocker (CCB) used primarily for the rapid reduction of blood pressure in hypertensive emergencies and certain cardiovascular conditions. It works by relaxing blood vessels and reducing cardiac workload, leading to improved blood flow and oxygen delivery.
North American market for Nifedipine Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nifedipine Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Nifedipine Injection include Pfizer, Bayer, Pharmaoffer, Mylan, AdvaCare, Teva, Cisen Pharmaceutical, Wuhan Binhu Shuanghe Pharmaceutical, Medcalo, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nifedipine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nifedipine Injection.
The Nifedipine Injection market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nifedipine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nifedipine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Bayer
Pharmaoffer
Mylan
AdvaCare
Teva
Cisen Pharmaceutical
Wuhan Binhu Shuanghe Pharmaceutical
Medcalo
Segment by Type
10mg/2ml
20mg/2ml
Segment by Application
Hypertension
Angina (Chest Pain)
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nifedipine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nifedipine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Nifedipine Injection 麻豆原创 Overview
1.1 Product Definition
1.2 Nifedipine Injection by Type
1.2.1 Global Nifedipine Injection 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 10mg/2ml
1.2.3 20mg/2ml
1.3 Nifedipine Injection by Application
1.3.1 Global Nifedipine Injection 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hypertension
1.3.3 Angina (Chest Pain)
1.4 Global Nifedipine Injection 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Nifedipine Injection Revenue 2020-2031
1.4.2 Global Nifedipine Injection Sales 2020-2031
1.4.3 Global Nifedipine Injection 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nifedipine Injection 麻豆原创 Competition by Manufacturers
2.1 Global Nifedipine Injection Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Nifedipine Injection Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Nifedipine Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nifedipine Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nifedipine Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nifedipine Injection, Product Type & Application
2.7 Global Key Manufacturers of Nifedipine Injection, Date of Enter into This Industry
2.8 Global Nifedipine Injection 麻豆原创 Competitive Situation and Trends
2.8.1 Global Nifedipine Injection 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Nifedipine Injection Players 麻豆原创 Share by Revenue
2.8.3 Global Nifedipine Injection Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nifedipine Injection 麻豆原创 Scenario by Region
3.1 Global Nifedipine Injection 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nifedipine Injection Sales by Region: 2020-2031
3.2.1 Global Nifedipine Injection Sales by Region: 2020-2025
3.2.2 Global Nifedipine Injection Sales by Region: 2026-2031
3.3 Global Nifedipine Injection Revenue by Region: 2020-2031
3.3.1 Global Nifedipine Injection Revenue by Region: 2020-2025
3.3.2 Global Nifedipine Injection Revenue by Region: 2026-2031
3.4 North America Nifedipine Injection 麻豆原创 Facts & Figures by Country
3.4.1 North America Nifedipine Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nifedipine Injection Sales by Country (2020-2031)
3.4.3 North America Nifedipine Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nifedipine Injection 麻豆原创 Facts & Figures by Country
3.5.1 Europe Nifedipine Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nifedipine Injection Sales by Country (2020-2031)
3.5.3 Europe Nifedipine Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nifedipine Injection 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Nifedipine Injection 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nifedipine Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Nifedipine Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nifedipine Injection 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Nifedipine Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nifedipine Injection Sales by Country (2020-2031)
3.7.3 Latin America Nifedipine Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nifedipine Injection 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Nifedipine Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nifedipine Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nifedipine Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nifedipine Injection Sales by Type (2020-2031)
4.1.1 Global Nifedipine Injection Sales by Type (2020-2025)
4.1.2 Global Nifedipine Injection Sales by Type (2026-2031)
4.1.3 Global Nifedipine Injection Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Nifedipine Injection Revenue by Type (2020-2031)
4.2.1 Global Nifedipine Injection Revenue by Type (2020-2025)
4.2.2 Global Nifedipine Injection Revenue by Type (2026-2031)
4.2.3 Global Nifedipine Injection Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Nifedipine Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nifedipine Injection Sales by Application (2020-2031)
5.1.1 Global Nifedipine Injection Sales by Application (2020-2025)
5.1.2 Global Nifedipine Injection Sales by Application (2026-2031)
5.1.3 Global Nifedipine Injection Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Nifedipine Injection Revenue by Application (2020-2031)
5.2.1 Global Nifedipine Injection Revenue by Application (2020-2025)
5.2.2 Global Nifedipine Injection Revenue by Application (2026-2031)
5.2.3 Global Nifedipine Injection Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Nifedipine Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Nifedipine Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Nifedipine Injection Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Pharmaoffer
6.3.1 Pharmaoffer Company Information
6.3.2 Pharmaoffer Description and Business Overview
6.3.3 Pharmaoffer Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pharmaoffer Nifedipine Injection Product Portfolio
6.3.5 Pharmaoffer Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Nifedipine Injection Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 AdvaCare
6.5.1 AdvaCare Company Information
6.5.2 AdvaCare Description and Business Overview
6.5.3 AdvaCare Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AdvaCare Nifedipine Injection Product Portfolio
6.5.5 AdvaCare Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Nifedipine Injection Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Cisen Pharmaceutical
6.7.1 Cisen Pharmaceutical Company Information
6.7.2 Cisen Pharmaceutical Description and Business Overview
6.7.3 Cisen Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cisen Pharmaceutical Nifedipine Injection Product Portfolio
6.7.5 Cisen Pharmaceutical Recent Developments/Updates
6.8 Wuhan Binhu Shuanghe Pharmaceutical
6.8.1 Wuhan Binhu Shuanghe Pharmaceutical Company Information
6.8.2 Wuhan Binhu Shuanghe Pharmaceutical Description and Business Overview
6.8.3 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio
6.8.5 Wuhan Binhu Shuanghe Pharmaceutical Recent Developments/Updates
6.9 Medcalo
6.9.1 Medcalo Company Information
6.9.2 Medcalo Description and Business Overview
6.9.3 Medcalo Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medcalo Nifedipine Injection Product Portfolio
6.9.5 Medcalo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nifedipine Injection Industry Chain Analysis
7.2 Nifedipine Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nifedipine Injection Production Mode & Process Analysis
7.4 Nifedipine Injection Sales and 麻豆原创ing
7.4.1 Nifedipine Injection Sales Channels
7.4.2 Nifedipine Injection Distributors
7.5 Nifedipine Injection Customer Analysis
8 Nifedipine Injection 麻豆原创 Dynamics
8.1 Nifedipine Injection Industry Trends
8.2 Nifedipine Injection 麻豆原创 Drivers
8.3 Nifedipine Injection 麻豆原创 Challenges
8.4 Nifedipine Injection 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Bayer
Pharmaoffer
Mylan
AdvaCare
Teva
Cisen Pharmaceutical
Wuhan Binhu Shuanghe Pharmaceutical
Medcalo

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.